Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Purpose Hypoxia-inducible factors HIF1alpha and HIF2alpha (HIFalphas) regulate the expression of a variety of genes encoding proteins related to angiogenesis and to anaerobic metabolism of cells exposed to hypoxic stress. Their putative role as markers of clinically relevant hypoxia and, therefore, as predictors of response to chemoradiotherapy is herein examined. Patients and methods Using immunohistochemistry, we assessed the expression of HIFalphas in normal head-neck mucosa and in 75 cancer specimens from patients with locally advanced squamous cell head-and-neck cancer (SCHNC), treated with concurrent carboplatin chemoradiotherapy. Results Head-and-neck mucosa from normal individuals did not show any HIF1alpha or HIF2alpha reactivity. SCHNC showed a varying expression of HIFalphas ranging through negative reactivity, to weak or focally strong cytoplasmic reactivity, or to strong diffuse cytoplasmic/nuclear reactivity. Fifty-two percent and 33% of cancer samples showed the latter expression pattern for HIF1alpha and HIF2alpha, respectively, and were considered to bear "high" HIF reactivity. Bone/cartilage involvement was more frequent in tumors with high HIF1alpha expression (p = 0.05). HIF1alpha and HIF2alpha overexpression were significantly associated with high microvessel density (p = 0.002 and 0.02, respectively) and with VEGF expression (p = 0.01 and 0.005, respectively). HIF1alpha was related to high thymidine phosphorylase expression (p = 0.03), whereas VEGF/KDR-a…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HIF-2α expression is also a marker of poor prognosis in glioblastoma (Li et al., 2009), neuroblastoma (Holmquist-Mengelbier et al., 2006), head and neck squamous carcinoma (Koukourakis et al., 2002), and non-small cell lung cancer (Giatromanolaki et al., 2001).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Koukourakis et al., 2002
In the citing paper
“HIF overexpression in clinical samples is associated with therapeutic resistance or decreased survival following IR or chemotherapy (Aebersold et al., 2001;Birner et al., 2001b;Koukourakis et al., 2002;Burri et al., 2003;Generali et al., 2006;Vergis et al., 2008).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Koukourakis et al., 2002
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Evaluation of survival data and two new rank order statistics arising in its consideration.
Mantel, N. (1966) · PubMed · Cited by 7,519
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
(1999) · PubMed · Cited by 2,204
Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S., & Scott, O. C. A. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-312-638 · Cited by 2,158
Talks, K. L., Turley, H., Gatter, K. C., Maxwell, P. H., Pugh, C. W., Ratcliffe, P. J., & Harris, A. L. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64554-3 · Cited by 1,312
Self-citationHuang, L. E., Arany, Z., Livingston, D. M., & Bunn, H. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.32253 · Cited by 1,190
Research works printed but not linked: 3
- Beatrice, 1998, Angiogenesis, Anticancer Res, 18, 4737
- Koukourakis, 2000, VEGF/KDR activated microvessel density (aMVD) vs. CD31 standard microvessel density (sMVD) in non-small cell lung cancer, Cancer Res, 60, 3088
- Aebersold, 2001, Expression of hypoxia-inducible factor-1alpha, Cancer Res, 61, 2911
Cited by
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
“, although other studies failed to replicate these result”
ResultHypoxia in cancer: significance and impact on clinical outcome
Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240
“Nevertheless, other investigators chose to also or even predominantly assess cytoplasmic expression [51, 52].”
BackgroundThe role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
Muz, B., de la Puente, P., Azab, F., & Azab, A. K. (2015) · Hypoxia · doi:10.2147/hp.s93413 · Cited by 2,066
“It was reported that head-and-neck cancer samples with high expression of HIF-1α and HIF-2α were more resistant to chemotherapy (carboplatin) compared to biopsies with low HIF-α expression which were chemo-sensitive.(104) Patients”
BackgroundThe Tumour Microenvironment after Radiotherapy: Mechanisms of Resistance and Recurrence
Barker, H. E., Paget, J. T. E., Khan, A. A., & Harrington, K. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3958 · Cited by 2,144
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712
“…Sivridis et al. (2002) Esophageal SCC Tzao et al. (2008) Gastric Griffiths et al. (2007) GIST, stomach Takahashi et al. (2003) Head-and-neck SCCc Koukourakis et al. (2002) Laryngeal Schrijvers et al. (2008) Lung, NSCLC Swinson et al. (2004) Lung, NSCLCd Giatromanolaki et al. (2001) Malignant…”
Metadata
- Authors
- Koukourakis, M. I., Giatromanolaki, A., Sivridis, E., Simopoulos, C., Turley, H., Talks, K., Gatter, K. C., & Harris, A. L.
- Affiliations
- Democritus University of Thrace (GR)
- John Radcliffe Hospital (GB)
- Corresponding author
- Koukourakis, Michael I
- Venue
- International Journal of Radiation Oncology*Biology*Physics
- Publisher
- Elsevier BV
- Published
- 2002-08
- Volume
- 53
- Issue
- 5
- Pages
- 1192-1202
- ISSN
- 0360-3016 (ISSN-L)
- OpenAlex
- W1983270572
- Cited by
- 361
- References
- 41
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 7 · 2023: 15 · 2022: 14 · 2021: 14 · 2020: 11 · 2019: 14 · 2018: 11 · 2017: 5 · 2016: 11 · 2015: 18 · 2014: 11 · 2013: 15 · 2012: 14
- FWCI
- 8.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- International Journal of Radiation Oncology*Biology*Physics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- hypoxia-inducible factor, HIF1A, HIF-2α, head and neck squamous cell carcinoma, tumor hypoxia, angiogenesis, chemoradiotherapy response, carboplatin, microvessel density, vascular endothelial growth factor, thymidine phosphorylase, prognostic factors, local recurrence-free survival, overall survival, KDR, tumor vasculature, locally advanced cancer
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Hypoxia, Antineoplastic Agents, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Humans, Immunohistochemistry, Neovascularization, Pathologic, Prognosis, Time Factors, Transcription Factors, Cohort Studies, Trans-Activators, Up-Regulation, Case-Control Studies, Carboplatin, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. https://app.cochat.ai/papers/10.1016/s0360-3016(02)02848-1
- The paper
- Koukourakis, M. I., Giatromanolaki, A., Sivridis, E., Simopoulos, C., Turley, H., Talks, K., Gatter, K. C., & Harris, A. L. (2002). Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/s0360-3016(02)02848-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.